Thermo Fisher Advances Gene Therapy with DeltaV Automation

Thermo Fisher

Prajakta Bhanap of Thermo Fisher Scientific discussed the company’s creation of Cellmation, a digital solution that dramatically streamlines the manufacture of cell therapies. For decades, the foundations of cancer treatment have been surgery, chemotherapy and radiation therapy. These continue to be critical mainstays of treatment, but in recent years new categories of treatment have helped transform the treatment outlook for many people with cancer.

Latest News

Calvin Butler to Join Emerson’s Board of Directors

Emerson today announced the appointment of Calvin Butler to its Board of Directors, effective August 1, 2024.

Emerson Reports Second Quarter 2024 Results; Updates 2024 Outlook

Emerson today reported results for the first quarter ended March 31, 2024.

Emerson’s New Flexible Control Package Helps OEMs and Small, Manufacturing Operations Develop...

The DeltaV Flex System provides scalable, subscription-based automation to reduce up-front cost and engineering complexity
Please enable JavaScript to use this website.